secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2022-09-07T23:59:59+00:00
Accession:  0001493152-22-025258
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals appoints Kirko Kirkov as Chief Commercial Officer effective Sept. 6, 2022
--------------------------------------------------------------------------------

- Base salary $150k/year; increases to $275k after one year contingent on corporate goals.
- Eligible for annual bonus up to 50% of salary (20% personal KPIs, 30% corporate performance).
- Upon board approval, granted options to purchase 3,000,000 shares vesting over 3 years.
- Kirkov brings 20+ years experience, most recently General Manager at Vertice Pharma.
- New position to oversee sales and marketing of commercial products under Elite label.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/0001493152-22-025258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-025258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer